As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Orthofix Medical Inc. The largest reported stake is Juniper Investment Company, LLC's, at 11%. 10 filings are on record since August 14, 2025 (Schedule 13D/A, May 27, 2026).
Sell to companies like Orthofix Medical Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Armistice Capital, LLC · Sole voting: 0 · Shared voting: 3,264,000 · Sole dispositive: 0 · Shared dispositive: 3,264,000 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: Juniper Targeted Opportunity Fund, L.P. · Sole voting: 3,461,216 · Shared voting: 0 · Sole dispositive: 3,461,216 · Shared dispositive: 0 · SCHEDULE 13D/A, 2026-05-27
- · Holder: Armistice Capital, LLC · Percent: 6.73% · SCHEDULE 13G/A
- · Reporting person: The Vanguard Group · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-03-27
- · Holder: Armistice Capital, LLC · Percent: 6.69% · SCHEDULE 13G/A
Orthofix Medical Inc. has 10 Schedule 13D or 13G filings on record since 2025-08-14. 2 holders' latest filing reports 5% or more of common stock, $0.10 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Juniper Investment Company, LLC | 11% | 4,442,543 | SCHEDULE 13D/A, 2026-05-27 | 2026-05-22 |
| Armistice Capital, LLC | 8.01% | 3,264,000 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Orthofix Medical Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Orthofix Medical Inc. and the records around it.
Orthofix Medical Inc. elsewhere on the record
Companies that share a holder
- Juniper Targeted Opportunity Fund, L.P. also filed stake reports on 3 other companies: Allient Inc. (Aug 2026), Lincoln Educational Services Corporation (Jun 2026), Artivion, Inc. (Aug 2025)
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Orthofix Medical Inc.
Get an email when Orthofix Medical Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Orthofix Medical Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Orthofix Medical Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Orthofix Medical Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P. | 3,461,216 | 0 | 3,461,216 | 0 | SCHEDULE 13D/A, 2026-05-27 |
| Juniper HF Investors II, LLC | 0 | 3,461,216 | 0 | 3,461,216 | SCHEDULE 13D/A, 2026-05-27 |
| Juniper Targeted Opportunities, L.P. | 935,901 | 0 | 935,901 | 0 | SCHEDULE 13D/A, 2026-05-27 |
| Juniper Targeted Opportunity Investors, LLC | 0 | 935,901 | 0 | 935,901 | SCHEDULE 13D/A, 2026-05-27 |
| Juniper Multi-Strategy Fund, L.P. | 45,426 | 0 | 45,426 | 0 | SCHEDULE 13D/A, 2026-05-27 |
| Juniper HF Investors, LLC | 0 | 45,426 | 0 | 45,426 | SCHEDULE 13D/A, 2026-05-27 |
| Juniper Investment Company, LLC | 0 | 4,442,543 | 0 | 4,442,543 | SCHEDULE 13D/A, 2026-05-27 |
| Alexis P. Michas | 0 | 4,442,543 | 0 | 4,442,543 | SCHEDULE 13D/A, 2026-05-27 |
| John A. Bartholdson | 0 | 4,442,543 | 0 | 4,442,543 | SCHEDULE 13D/A, 2026-05-27 |
| Armistice Capital, LLC | 0 | 3,264,000 | 0 | 3,264,000 | SCHEDULE 13G/A, 2026-08-14 |
| Steven Boyd | 0 | 3,264,000 | 0 | 3,264,000 | SCHEDULE 13G/A, 2026-08-14 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-27 |
The latest filing identifies Orthofix Medical Inc. by CUSIP 68752M108 and gives its principal executive office as 3451 PLANO PARKWAY, LEWISVILLE, TX 75056 (SCHEDULE 13G/A, 2026-08-14).
Source of funds (Item 3)
Item 3 is hereby amended and supplemented by adding the following information: As of the date hereof, the Reporting Persons are deemed to beneficially own the Subject Shares as detailed in Items 1 and 5.Juniper Investment Company, LLC, SCHEDULE 13D/A, 2026-05-27
Purpose of Transaction (Item 4)
Juniper Investment Company, LLC
Item 4 is hereby amended and supplemented by adding the following information. Between February 13, 2026, and May 22, 2026, Juniper Targeted Opportunity Fund, L.P. purchased 657,926 shares at an aggregate purchase price of approximately $7,413,751, which includes brokerage commissions, in the open market.Item 4 of the SCHEDULE 13D/A filed 2026-05-27
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | Armistice Capital, LLC | 7.54% | SCHEDULE 13G/A |
| 2025-09-25 | Juniper Investment Company, LLC | 7.2% | SCHEDULE 13D/A |
| 2025-10-21 | Juniper Investment Company, LLC | 8.2% | SCHEDULE 13D/A |
| 2025-11-14 | Armistice Capital, LLC | 5.65% | SCHEDULE 13G/A |
| 2026-02-13 | Juniper Investment Company, LLC | 9.6% | SCHEDULE 13D/A |
| 2026-02-17 | Armistice Capital, LLC | 6.69% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-05-15 | Armistice Capital, LLC | 6.73% | SCHEDULE 13G/A |
| 2026-05-27 | Juniper Investment Company, LLC | 11% | SCHEDULE 13D/A |
| 2026-08-14 | Armistice Capital, LLC | 8.01% | SCHEDULE 13G/A |
Questions about who owns Orthofix Medical Inc.
Who owns Orthofix Medical Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Orthofix Medical Inc.: Juniper Investment Company, LLC (11%, Schedule 13D/A, filed 2026-05-27) and Armistice Capital, LLC (8.01%, Schedule 13G/A, filed 2026-08-14).
Who are the largest shareholders of Orthofix Medical Inc.?
By the share each holder's latest filing reports, the largest holders of Orthofix Medical Inc. on this page are Juniper Investment Company, LLC (11%) and Armistice Capital, LLC (8.01%).
When did Juniper Investment Company, LLC buy into Orthofix Medical Inc.?
The filings give report dates, not purchase dates. The earliest filing from Juniper Investment Company, LLC on this page is the Schedule 13D/A, filed 2025-09-25, reporting 7.2%; its latest, Schedule 13D/A filed 2026-05-27, reports 11%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Orthofix Medical Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| June 11, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 9, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Orthofix Medical Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.